A Clinical Trial of PRAX-114 in Participants With PTSD
Researchers are comparing 60 mg PRAX-114 or 40 mg PRAX-114, 40 mg PRAX-114 and placebo to find out how the approaches affect post-traumatic stress symptoms in people with PTSD.
Understand this study
What is this study about?
Researchers are comparing 60 mg PRAX-114 or 40 mg PRAX-114, 40 mg PRAX-114 and placebo to find out how the approaches affect post-traumatic stress symptoms in people with PTSD.
Who could participate?
This study is for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- Phoenix and 16 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 11
- Sponsor
- Praxis Precision Medicines
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05260541
- Official title
Show the full official title
A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Post-Traumatic Stress Disorder
Recruitment & locations
Phoenix · Little Rock · Rogers
14 more locations
- Lemon Grove
- Westlake Village
- Fort Myers
- Decatur
- Boston
- Las Vegas
- Cincinnati
- Dayton
- Oklahoma City
- Allentown
- Media
- Austin
- Dallas
- Everett
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing 60 mg PRAX-114 or 40 mg PRAX-114, 40 mg PRAX-114 and placebo to find out how the approaches affect post-traumatic stress symptoms in people with PTSD.
Who is behind this study?
The study sponsor is Praxis Precision Medicines, a pharmaceutical company.
Does this study involve medication?
Yes. The study involves medication, including 60 mg PRAX-114 or 40 mg PRAX-114, Placebo and 40 mg PRAX-114.
Who can participate?
This study is for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
